SRPT

Sarepta Therapeutics, Inc.

SRPT · CIK 873303 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$0.4B
20182025
Net Income−$0.4B
20182025
Operating CF−$0.2B
20182025
Free Cash Flow−$0.3B
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.4B$1.9B$1.2B$0.9B$0.7B$0.1B$0.1B$0.1B
Cost of Revenue$0.0B———————
Gross Profit$-0.0B———————
R&D Expense—————$0.2B$0.2B$0.1B
SG&A Expense$0.5B$0.6B$0.5B$0.5B$0.3B$0.1B$0.1B$0.1B
Operating Income$-0.7B$0.2B$-0.3B$-0.5B$-0.5B$-0.2B$-0.2B$-0.1B
Net Income$-0.4B$0.2B$-0.5B$-0.7B$-0.4B$-0.2B$-0.2B$-0.1B
EPS (Basic)$-3.93$2.47$-5.80$-8.03———$-0.37
EPS (Diluted)$-3.93$2.34$-5.80$-8.03———$-0.37

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$3.3B$4.0B$3.3B$3.1B$3.1B$3.0B$1.8B$1.6B
Current Assets$2.5B$3.1B$2.6B$2.6B$2.6B$2.5B$1.5B$1.4B
Cash & Equivalents$0.8B$1.1B$0.4B$1.0B$2.1B$1.5B$0.8B$0.4B
Total Liabilities$2.2B$2.4B$2.4B$2.7B$2.2B$2.2B$1.0B$0.6B
Current Liabilities$1.1B$0.7B$0.7B$0.6B$0.5B$0.4B$0.3B$0.2B
Stockholders' Equity$1.1B$1.5B$0.9B$0.4B$0.9B$0.8B$0.8B$1.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$-0.2B$-0.2B$-0.5B$-0.3B$-0.4B$0.1B$-0.5B$-0.4B
Investing Cash Flow$0.1B$0.8B$-0.2B$-1.0B$0.5B$-0.1B$0.3B$-0.4B
Capital Expenditures$0.1B$0.1B$0.1B$0.0B$0.0B$0.1B$0.1B$0.1B
Financing Cash Flow$-0.2B$0.1B$0.1B$0.2B$0.6B$0.7B$0.6B$0.5B
← Companies